InMed Pharmaceuticals, Mentari Therapeutics To Merge
19/5 14:30
(RTTNews) - InMed Pharmaceuticals (INM) has entered into a definitive merger agreement for an all-stock transaction with Mentari Therapeutics, a privately-held biotechnology company developing therapies for migraine prevention, Indigo Merger Sub Corp. a subsidiary of InMed, and I...